The Journal of Experimental Medicine · 1997 · 94 citations · 37 references
Life SciencesImmunologyMolecular BiologyCell SignalingMolecular VirologySignal TransductionAntiviral ImmunityB Cell ActivationB Cell BiologyB-cell ResponsesOncogenic VirusesViral OncogenesisEpstein-barr Virus LatencyEpstein-barr Virus OncogenesisGene Promoter BindingNf-kappa B-dependent TranscriptionNf-κb SignalingTranscriptional ActivationViral Promoter ActivationViral Promoter Recognition
Epstein-Barr virus (EBV), an oncogenic human herpesvirus, binds to and infects normal human B lymphocytes via CD21, the CR2 complement receptor. Studies of the mechanisms that enable EBV to infect nonactivated, noncycling B cells provide compelling evidence for a sequence of events in which EBV binding to CD21 on purified resting human B cells rapidly activates the NF-kappaB transcription factor, which, in turn, binds to and mediates transcriptional activation of Wp, the initial viral latent gene promoter. Thus, EBV binding to its cellular receptor on resting B cells triggers an NF-kappaB-dependent intracellular signaling pathway which is required for infection.
37
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Amer A. Beg, David Baltimore · Science · 1996 · 3.1K citations
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Ranjan Sen, David Baltimore · Cell · 1986 · 2.8K citations · Full text
Suppression of TNF-α-Induced Apoptosis by NF-κB
Daniel J. Van Antwerp, Séamus J. Martin, Tal Kafri et al. · Science · 1996 · 2.6K citations